Altmetric

Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: Impact of timing of treatment initiation

File Description SizeFormat 
Maher et al_RECAP study benefit chart letter_journal revisions_31Jan2019_clean.docxFile embargoed until 05 April 2020239.52 kBMicrosoft Word    Request a copy
Title: Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: Impact of timing of treatment initiation
Authors: Maher, TM
Lancaster, LH
Jouneau, S
Morrison, L
Lederer, DJ
Molina-Molina, M
Bendstrup, E
Kirchgaessler, K-U
Gilberg, F
Axmann, J
Petzinger, U
Noble, PW
Item Type: Journal Article
Issue Date: 5-Apr-2019
Date of Acceptance: 3-Apr-2019
URI: http://hdl.handle.net/10044/1/69894
DOI: https://dx.doi.org/10.1513/AnnalsATS.201810-720RL
ISSN: 2329-6933
Publisher: American Thoracic Society
Journal / Book Title: Annals of the American Thoracic Society
Copyright Statement: © 2019 by the American Thoracic Society
Publication Status: Published online
Conference Place: United States
Embargo Date: 2020-04-05
Online Publication Date: 2019-04-05
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons